Brown Advisory’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Brown Advisory’s Portfolio KERX Stock Details KERX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-15,444	Closed	-$53K	–	1388
2018 Q3	$53K	Buy	15,444 +1,500	+11%	+$5.41K	﹤0.01%	1312
2018 Q2	$52K	Hold	13,944	–	–	﹤0.01%	1267
2018 Q1	$57K	Buy	13,944 +1,350	+11%	+$6.29K	﹤0.01%	1154
2017 Q4	$59K	Buy	+12,594	New	+$69.4K	﹤0.01%	1200
2017 Q2	–	Sell	-13,161	Closed	-$81K	–	1258
2017 Q1	$81K	Buy	+13,161	New	+$72.1K	﹤0.01%	1142

Brown Advisory's KERX Position: Q4 2018 in Review

Brown Advisory sold out of Keryx Biopharmaceuticals Inc (KERX) in Q4 2018, closing a stake of 15,444 shares — an estimated $53K sold.

Brown Advisory first reported a position in KERX in Q1 2017 and held it in 5 quarters. The position peaked at $81K in Q1 2017. 1 fund tracked by Wall St. Rank holds KERX as of Q4 2018.

Brown Advisory reported no remaining Keryx Biopharmaceuticals Inc position as of Q4 2018 after selling out during the quarter.
Brown Advisory sold 15,444 Keryx Biopharmaceuticals Inc shares in Q4 2018, an estimated $53K.
Brown Advisory first reported a position in Keryx Biopharmaceuticals Inc in Q1 2017 and held it in 5 quarters.
Brown Advisory's Keryx Biopharmaceuticals Inc position peaked at $81K in Q1 2017.
1 fund tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q4 2018.

Based on Brown Advisory's 13F filing for Q4 2018, filed 13 Feb 2019.